Abstract
Mitochondria are organelles playing pivotal roles in a range of diverse cellular functions, from energy generation to redox homeostasis and apoptosis regulation. Their loss of functionality may indeed contribute to the development of aging and age-related neurodegenerative disorders. Recently, mitochondria have been shown to exhibit peculiar features in pluripotent stem cells (PSCs). Moreover, an extensive restructuring of mitochondria has been observed during the process of cellular reprogramming, i.e. the conversion of somatic cells into induced pluripotent stem cells (iPSCs). These transformation events impact mitochondrial number, morphology, activity, cellular metabolism, and mtDNA integrity. PSCs retain the capability to self-renew indefinitely and to give rise to virtually any cell type of the body and thus hold great promise in medical research. Understanding the mitochondrial properties of PSCs, and how to modulate them, may thus help to shed light on the features of stemness and possibly increase our knowledge on cellular identity and differentiation pathways. Here, we review these recent findings and discuss their implications in the context of stem cell biology, aging research, and regenerative medicine.
Journal Section:
Editor's choice
References
1.
Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676.
[PubMed]
2.
Sancho-Martinez I, Baek SH, Izpisua Belmonte JC: Lineage conversion methodologies meet the reprogramming toolbox. Nat Cell Biol 2012;14:892-899.
[PubMed]
3.
Cho YM, et al: Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the spontaneous differentiation of human embryonic stem cells. Biochem Biophys Res Commun 2006;348:1472-1478.
[PubMed]
4.
St John JC, et al: The expression of mitochondrial DNA transcription factors during early cardiomyocyte in vitro differentiation from human embryonic stem cells. Cloning Stem Cells 2005;7:141-153.
[PubMed]
5.
Facucho-Oliveira JM, et al: Mitochondrial DNA replication during differentiation of murine embryonic stem cells. J Cell Sci 2007;120(Pt 22):4025-4034.
[PubMed]
6.
Todd LR, et al: Growth factor erv1-like modulates Drp1 to preserve mitochondrial dynamics and function in mouse embryonic stem cells. Mol Biol Cell 2010;21:1225-1236.
[PubMed]
7.
Prigione A, et al: The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells 2010;28:721-733.
[PubMed]
8.
Suhr ST, et al: Mitochondrial rejuvenation after induced pluripotency. PLoS One 2010;5:e14095.
[PubMed]
9.
Varum S, et al: Energy metabolism in human pluripotent stem cells and their differentiated counterparts. PLoS One 2011;6:e20914.
[PubMed]
10.
Folmes CD, et al: Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab 2011;14:264-271.
[PubMed]
11.
Armstrong L, et al: Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells. Stem Cells 2010;28:661-673.
[PubMed]
12.
Chen T, et al: Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells. Aging Cell 2011;10:908-911.
[PubMed]
13.
Menendez JA, et al: mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging. Cell Cycle 2011;10:3658-3677.
[PubMed]
14.
Prigione A, Adjaye J: Modulation of mitochondrial biogenesis and bioenergetic metabolism upon in vitro and in vivo differentiation of human ES and iPS cells. Int J Dev Biol 2010;54:1729-1741.
[PubMed]
15.
Mandal S, et al: Mitochondrial function controls proliferation and early differentiation potential of embryonic stem cells. Stem Cells 2011;29:486-495.
[PubMed]
16.
Vander Heiden MG, Cantley LC, Thompson CB: Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009;324:1029-1033.
[PubMed]
17.
Zhang J, et al: UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells. EMBO J 2011;30:4860-4873.
[PubMed]
18.
Panopoulos AD, et al: The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming. Cell Res 2011;22:168-177.
[PubMed]
19.
Prigione A, et al: Mitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations. PLoS One 2011;6:e27352.
[PubMed]
20.
Prigione A, et al: Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming. Stem Cells 2011;29:1338-1348.
[PubMed]
21.
Zhu S, et al: Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 2010;7:651-655.
[PubMed]
22.
Chen CT, et al: Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells 2008;26:960-968.
[PubMed]
23.
Baris OR, et al: The mitochondrial electron transport chain is dispensable for proliferation and differentiation of epidermal progenitor cells. Stem Cells 2011;29:1459-1468.
[PubMed]
24.
Suda T, Takubo K, Semenza GL: Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell 2011;9:298-310.
[PubMed]
25.
Prigione A, et al: HIF1α modulates cell fate reprogramming through early glycolytic shift and up-regulation of PDK1-3 and PKM2. Stem Cells 2013, DOI: 10.1002/stem.1552.
[PubMed]
26.
Yanes O, et al: Metabolic oxidation regulates embryonic stem cell differentiation. Nat Chem Biol 2010;6:411-417.
[PubMed]
27.
Ralser M, et al: Dynamic rerouting of the carbohydrate flux is key to counteracting oxidative stress. J Biol 2007;6:10.
[PubMed]
28.
Kazak L, Reyes A, Holt IJ: Minimizing the damage: repair pathways keep mitochondrial DNA intact. Nat Rev Mol Cell Biol 2012;13:659-671.
[PubMed]
29.
Prigione A, Cortopassi G: Mitochondrial DNA deletions induce the adenosine monophosphate-activated protein kinase energy stress pathway and result in decreased secretion of some proteins. Aging Cell 2007;6:619-630.
[PubMed]
30.
Van Haute L, et al: Human embryonic stem cells commonly display large mitochondrial DNA deletions. Nat Biotechnol 2013;31:20-23.
[PubMed]
31.
Kelly RD, et al: Mitochondrial DNA haplotypes define gene expression patterns in pluripotent and differentiating embryonic stem cells. Stem Cells 2012;31:703-716.
[PubMed]
32.
Cheng L, et al: Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. Cell Stem Cell 2012;10:337-344.
[PubMed]
33.
Cherry AB, et al: Induced Pluripotent Stem Cells with a Pathological Mitochondrial DNA Deletion. Stem Cells 2013;31:1287-1297.
[PubMed]
34.
Fujikura J, et al: Induced pluripotent stem cells generated from diabetic patients with mitochondrial DNA A3243G mutation. Diabetologia 2012;55:1689-1698.
[PubMed]
35.
Folmes CD, et al: Disease-Causing Mitochondrial Heteroplasmy Segregated Within Induced Pluripotent Stem Cell Clones Derived from a Patient with MELAS. Stem Cells 2013;31:1298-1308.
[PubMed]
36.
Mahmoudi S, Brunet A: Aging and reprogramming: a two-way street. Curr Opin Cell Biol 2012;24:744-756.
[PubMed]
37.
Parker GC, Acsadi G, Brenner CA: Mitochondria: determinants of stem cell fate? Stem Cells Dev 2009;18:803-806.
[PubMed]
38.
Birket MJ, et al: A reduction in ATP demand and mitochondrial activity with neural differentiation of human embryonic stem cells. J Cell Sci 2011;124(Pt 3):348-358.
[PubMed]
© 2013 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2013
You do not currently have access to this content.
